Dental News - To reduce use of local anesthetic injections, Oral Science offers Cetacaine

Dental Tribune International

Fri. 4 June 2010

save

In September 2009, Oral Science introduced Cetacaine, a non-injectable topical anesthetic well-suited to controlling pain of scaling and root planing, providing patients with an efficient, cost-effective product. Costing only about US$2 for a full-mouth application, the included 14 g bottle yields up to 34 full-mouth applications.

The new unique dispenser cap for luer lock syringes allows the clinician to use only what he or she needs, without exceeding the 0.4 ml maximum dose.

Cetacaine’s triple-active formula (benzocaine 14 percent, butamben 2 percent, tetracaine hydrochloride 2 percent) has onset within 30 to 60 seconds and duration typically lasts 30 to 60 minutes.

Dr Howard Tenenbaum, a professor of periodontology based in Toronto, said he has “reduced his use of local anesthetic injections for recall and initial therapy scaling and root planing treatment by at least 80 percent with Cetacaine.”

The kit contains a 14 g bottle of Cetacaine Topical Anesthetic Liquid with a new unique dispenser cap, 20 Vista 1.2 mL luer lock syringes and 20 Vista-Probe 27 ga tips.

Cetylite now offers a 14 g or 30 g replacement bottle of Cetacaine Liquid with the new unique luer lock dispenser cap. The cap is universal to fit all luer lock syringes.

This unique design also allows for the single dip of a microbrush, which is ideal for pre-injection or other procedures requiring site-specific topical anesthesia.

Oral Science is the exclusive distributor of Cetylite’s Cetacaine in Canada. The company is also offering a free Cetacaine Kit or 30 g bottle when you purchase two Cetacaine kits or two 30 g bottles.

Oral Science’s mission is to create synergy between dental professionals and exceptional treatment protocols. It specializes in creating optimal clinical results for periodontal treatment, pain management, caries management, tooth sensitivity, laser dentistry and whitening.

To post a reply please login or register

Onset: Making local anesthetic better

NEW YORK, N.Y., USA: It was approximately 11 years ago when Mic Falkel, DDS, founder of Onpharma, first recognized that the performance and inconsistency of...

GLO Science offers webinar for dental professionals

GLO Science, a leading developer of teeth-whitening products and the winner of the 2012 Edison Award for excellence in innovation and design, is presenting ...

ADA: Selective use of CBCT offers advanced point-of-care imaging

CHICAGO, Ill., USA: In the August issue of The Journal of the American Dental Association, the American Dental Association’s Council on Scientific ...

DentalOne Partners joins forces with Forward Science to detect oral cancer

HOUSTON, Texas, USA: DentalOne Partners recently joined forces with Forward Science, the manufacturer of OralID. Forward Science’s flagship product, ...

Midwinter Meeting offers plenty of ways to learn

CHICAGO, Ill., USA: The Chicago Dental Society’s 2017 Midwinter Meeting offered plenty of educational opportunities, not only in the lecture halls but...

New study could help reduce pain in oral cancer patients

NEW YORK, US: Oral tumours can cause agonising pain and thus greatly impair the quality of life of patients. Researchers from the New York University ...

Nanorobots quickly and effectively target fungal infections in the oral cavity

PHILADELPHIA, US: Because of the threat to global health, the World Health Organization has initiated efforts to strengthen the global response to fungal ...

UCLA researchers develop technology to dramatically reduce peri-implantitis

LOS ANGELES, US: With reported cases as high as 19%, the battle against peri-implantitis has left clinicians and researchers constantly searching for ways ...

AGD’s meeting in Detroit to offer oral cancer screenings to public

CHICAGO, Ill., USA: General dentists and dental team members will gather in Detroit for the Academy of General Dentistry (AGD) 2014 Annual Meeting & ...

First-ever study to examine use of anti-ageing drug in periodontal disease

SEATTLE, US: Ageing greatly affects overall health and is the greatest risk factor for cardiovascular disease, Alzheimer’s disease and periodontal ...

Education

Live webinar
Thu. 9 May 2024
8:00 PM EST (New York)